Another Case of Bell's Palsy Recurrence After Pfizer-BioNTech COVID-19 Vaccination.
bell's palsy
covid vaccination
pandemic
recurrence
safety
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
accepted:
28
07
2022
entrez:
1
8
2022
pubmed:
2
8
2022
medline:
2
8
2022
Statut:
epublish
Résumé
Twenty-seven months into the current pandemic and 18 months after vaccinations were made available, there are still relatively limited data on the incidence of recurrent Bell's Palsy after the administration of mRNA-based vaccines. The authors continue to believe that it is through rigorous reporting that the true incidence can be tabulated eventually.
Identifiants
pubmed: 35910698
doi: 10.7759/cureus.27422
pmc: PMC9334026
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e27422Informations de copyright
Copyright © 2022, Zhang et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Lancet Infect Dis. 2021 Apr;21(4):450-452
pubmed: 33639103
J Neurol. 2020 Jul;267(7):1896-1905
pubmed: 30923934
Lancet. 2017 Sep 23;390(10101):1511-1520
pubmed: 28754494
Brain Behav Immun Health. 2021 May;13:100217
pubmed: 33594349
J Neurol. 2021 Oct;268(10):3589-3591
pubmed: 33611630
J Mol Neurosci. 2015 May;56(1):164-76
pubmed: 25527444
Therapie. 2021 Jul-Aug;76(4):365-367
pubmed: 33858693
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609